XCELL THERAPEUTICS
Verified Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$113—170m (Dealroom.co estimates Mar 2021.)
Company register number 5348600230
Seoul South Korea (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
KRW33.7b | Series C | ||
| Total Funding | 000k | ||
Recent News about XCELL THERAPEUTICS
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.